TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China sales ...
China-based GDS Holdings (GDS) is surging 6% after investment bank TD Cowen raised its price target on the shares. The ...
TD Cowen initiated coverage of Repligen (RGEN) with a Buy rating and $200 price target Repligen is well positioned for “industry-leading” ...
TD Cowen has downgraded Merck (NYSE:MRK) to hold from buy, citing Keytruda's impending loss of market exclusivity, or LOE. The bank said it no longer sees "viable arguments" for outperformance in the ...
Shares of Merck & Co. Inc. fell more than 0.5% on Monday afternoon, tracking their fifth consecutive decline in the worst ...
The New Hampshire-based company is opening new gyms around the country, spurred by a CEO change that has helped propel its ...
On Sunday, Trump said he would instruct the Treasury to stop minting pennies, calling the process wasteful. In particular, he flagged in a social media post that producing pennies "literally" costs ...
DeepSeek has quickly gained attention in AI with its R1 model, which delivers high performance at a lower cost.
Liam Griffin, long one of the pillars of Irvine’s tech scene, will be leaving chipmaker Skyworks Solutions Inc., yielding the ...
Logistics Management Group News Editor Jeff Berman recently interviewed Jason Seidl, Managing Director, Industrials - ...
TD Cowen analyst Ritu Baral maintained a Buy rating on Neurogene (NGNE – Research Report) today. The company’s shares closed yesterday at ...